28
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The MOBI-Kids Study Protocol: Challenges in Assessing Childhood and Adolescent Exposure to Electromagnetic Fields from Wireless Telecommunication Technologies and Possible Association with Brain Tumor Risk

      research-article
      1 , * , 3 , 4 , 5 , 1 , 6 , 7 , 8 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 11 , 11 , 6 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 25 , 25 , 27 , 27 , 27 , 27 , 28 , 28 , 28 , 29 , 29 , 1 , 1 , 7 , 30 , 31 , 32 , 33 , 34 , 34 , 35 , 36 , 37 , 37 , 38 , 3 , 4 , 5 , 39 , 40 , 41 , 42 , 42 , 43 , 8 , 44 , 45 , 45 , 3 , 4 , 5
      Frontiers in Public Health
      Frontiers Media S.A.
      children, adolescents, brain tumors, ELF–EMF, mobile phones, RF-EMF

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The rapid increase in mobile phone use in young people has generated concern about possible health effects of exposure to radiofrequency (RF) and extremely low frequency (ELF) electromagnetic fields (EMF). MOBI-Kids, a multinational case–control study, investigates the potential effects of childhood and adolescent exposure to EMF from mobile communications technologies on brain tumor risk in 14 countries. The study, which aims to include approximately 1,000 brain tumor cases aged 10–24 years and two individually matched controls for each case, follows a common protocol and builds upon the methodological experience of the INTERPHONE study. The design and conduct of a study on EMF exposure and brain tumor risk in young people in a large number of countries is complex and poses methodological challenges. This manuscript discusses the design of MOBI-Kids and describes the challenges and approaches chosen to address them, including: (1) the choice of controls operated for suspected appendicitis, to reduce potential selection bias related to low response rates among population controls; (2) investigating a young study population spanning a relatively wide age range; (3) conducting a large, multinational epidemiological study, while adhering to increasingly stricter ethics requirements; (4) investigating a rare and potentially fatal disease; and (5) assessing exposure to EMF from communication technologies. Our experience in thus far developing and implementing the study protocol indicates that MOBI-Kids is feasible and will generate results that will contribute to the understanding of potential brain tumor risks associated with use of mobile phones and other wireless communications technologies among young people.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: not found
          • Article: not found

          Carcinogenicity of radiofrequency electromagnetic fields.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study.

            The rapid increase in mobile telephone use has generated concern about possible health risks related to radiofrequency electromagnetic fields from this technology. An interview-based case-control study with 2708 glioma and 2409 meningioma cases and matched controls was conducted in 13 countries using a common protocol. A reduced odds ratio (OR) related to ever having been a regular mobile phone user was seen for glioma [OR 0.81; 95% confidence interval (CI) 0.70-0.94] and meningioma (OR 0.79; 95% CI 0.68-0.91), possibly reflecting participation bias or other methodological limitations. No elevated OR was observed > or =10 years after first phone use (glioma: OR 0.98; 95% CI 0.76-1.26; meningioma: OR 0.83; 95% CI 0.61-1.14). ORs were or =1640 h, the OR was 1.40 (95% CI 1.03-1.89) for glioma, and 1.15 (95% CI 0.81-1.62) for meningioma; but there are implausible values of reported use in this group. ORs for glioma tended to be greater in the temporal lobe than in other lobes of the brain, but the CIs around the lobe-specific estimates were wide. ORs for glioma tended to be greater in subjects who reported usual phone use on the same side of the head as their tumour than on the opposite side. Overall, no increase in risk of glioma or meningioma was observed with use of mobile phones. There were suggestions of an increased risk of glioma at the highest exposure levels, but biases and error prevent a causal interpretation. The possible effects of long-term heavy use of mobile phones require further investigation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The INTERPHONE study: design, epidemiological methods, and description of the study population.

              The very rapid worldwide increase in mobile phone use in the last decade has generated considerable interest in the possible health effects of exposure to radio frequency (RF) fields. A multinational case-control study, INTERPHONE, was set-up to investigate whether mobile phone use increases the risk of cancer and, more specifically, whether the RF fields emitted by mobile phones are carcinogenic. The study focused on tumours arising in the tissues most exposed to RF fields from mobile phones: glioma, meningioma, acoustic neurinoma and parotid gland tumours. In addition to a detailed history of mobile phone use, information was collected on a number of known and potential risk factors for these tumours. The study was conducted in 13 countries. Australia, Canada, Denmark, Finland, France, Germany, Israel, Italy, Japan, New Zealand, Norway, Sweden, and the UK using a common core protocol. This paper describes the study design and methods and the main characteristics of the study population. INTERPHONE is the largest case-control study to date investigating risks related to mobile phone use and to other potential risk factors for the tumours of interest and includes 2,765 glioma, 2,425 meningioma, 1,121 acoustic neurinoma, 109 malignant parotid gland tumour cases and 7,658 controls. Particular attention was paid to estimating the amount and direction of potential recall and participation biases and their impact on the study results.
                Bookmark

                Author and article information

                Contributors
                URI : http://frontiersin.org/people/u/171557
                URI : http://frontiersin.org/people/u/177327
                URI : http://frontiersin.org/people/u/138468
                URI : http://frontiersin.org/people/u/177747
                URI : http://frontiersin.org/people/u/22880
                URI : http://frontiersin.org/people/u/141610
                URI : http://frontiersin.org/people/u/181669
                URI : http://frontiersin.org/people/u/34985
                URI : http://frontiersin.org/people/u/176766
                URI : http://frontiersin.org/people/u/177540
                URI : http://frontiersin.org/people/u/177506
                URI : http://frontiersin.org/people/u/29329
                URI : http://frontiersin.org/people/u/176827
                URI : http://frontiersin.org/people/u/176808
                URI : http://frontiersin.org/people/u/176804
                URI : http://frontiersin.org/people/u/116872
                URI : http://frontiersin.org/people/u/33725
                URI : http://frontiersin.org/people/u/177615
                URI : http://frontiersin.org/people/u/180344
                URI : http://frontiersin.org/people/u/177650
                URI : http://frontiersin.org/people/u/173983
                URI : http://frontiersin.org/people/u/176963
                URI : http://frontiersin.org/people/u/176777
                URI : http://frontiersin.org/people/u/180105
                URI : http://frontiersin.org/people/u/181651
                URI : http://frontiersin.org/people/u/122209
                URI : http://frontiersin.org/people/u/180125
                URI : http://frontiersin.org/people/u/139843
                Journal
                Front Public Health
                Front Public Health
                Front. Public Health
                Frontiers in Public Health
                Frontiers Media S.A.
                2296-2565
                23 September 2014
                2014
                : 2
                : 124
                Affiliations
                [1] 1Cancer and Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center , Ramat Gan, Israel
                [2] 2Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv, Israel
                [3] 3Centre for Research in Environmental Epidemiology (CREAL) , Barcelona, Spain
                [4] 4Universitat Pompeu Fabra (UPF) , Barcelona, Spain
                [5] 5Ciber Epidemiología y Salud Pública (CIBERESP) , Barcelona, Spain
                [6] 6Center for Public Health, Institute of Environmental Health, Medical University Vienna , Vienna, Austria
                [7] 7Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin , Turin, Italy
                [8] 8Division Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University , Utrecht, Netherlands
                [9] 9Radio Technology Research Department, Electronics and Telecommunication Research Institute (ETRI) , Daejeon, South Korea
                [10] 10Centre for Radiation, Chemical and Environmental Hazards, Public Health England , Chilton, UK
                [11] 11Department of Epidemiology and Preventive Medicine, Monash University, Melbourne , VIC, Australia
                [12] 12Department of Electrical Engineering, Tokyo Metropolitan University , Tokyo, Japan
                [13] 13Whist Laboratory , Paris, France
                [14] 14The University of Sydney , Sydney, NSW, Australia
                [15] 15Telecom Institute for Child Health Research Western Australia , Perth, WA, Australia
                [16] 16Clinical Institute of Neurology, Medical University Vienna , Vienna, Austria
                [17] 17McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health , Ottawa, ON, Canada
                [18] 18Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa , Ottawa, ON, Canada
                [19] 19Children’s Hospital of Eastern Ontario , Ottawa, ON, Canada
                [20] 20University of Ottawa , Ottawa, ON, Canada
                [21] 21Ottawa Hospital Research Institute , Ottawa, ON, Canada
                [22] 22Children’s Hospital of Eastern Ontario Research Institute , Ottawa, ON, Canada
                [23] 23Research, Prevention and Cancer Control, Cancer Care Ontario , Ontario, ON, Canada
                [24] 24Cancer Control Research, British Columbia Cancer Agency , Vancouver, BC, Canada
                [25] 25French National Registry of Childhood Solid Tumors, CHU , Nancy, France
                [26] 26UMRS 1018, CESP, INSERM , Villejuif, France
                [27] 27Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital of Munich (LMU) , Munich, Germany
                [28] 28Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens , Athens, Greece
                [29] 29Centre for Cancer Epidemiology, Tata Memorial Centre , Mumbai, India
                [30] 30Unit of Cancer Epidemiology, Citta’ della Salute e della Scienza, University of Turin , Turin, Italy
                [31] 31Neuroepidemiology Research Unit, Instituto Nazionale Neurologico C. Besta , Milan, Italy
                [32] 32Unit of Occupational and Environmental Epidemiology, Institute for the Study and Prevention of Cancer , Florence, Italy
                [33] 33Department of Medical and Surgical Sciences, University of Bologna , Bologna, Italy
                [34] 34Department of Public Health, Tokyo Women’s Medical University , Tokyo, Japan
                [35] 35Department of Preventive Medicine, Dankook University College of Medicine , Cheonan, South Korea
                [36] 36Department of Public Health, Graduate School of Dankook University , Cheonan, South Korea
                [37] 37Centre for Public Health Research, Massey University , Wellington, New Zealand
                [38] 38School of Population Health, University of Auckland , Auckland, New Zealand
                [39] 39Centro de Investigación en Salud y Medio Ambiente (CYSMA), Universidad de Huelva , Huelva, Spain
                [40] 40Ciber Epidemiología y Salud Pública (CIBERESP) , Huelva, Spain
                [41] 41Cancer and Environmental Epidemiology Area, National Center for Epidemiology, Carlos III Institute of Health , Madrid, Spain
                [42] 42Ciber Epidemiología y Salud Pública (CIBERESP) , Madrid, Spain
                [43] 43Área de Medicina Preventiva y Salud Pública, Universitat de Valencia , Valencia, Spain
                [44] 44Department of Paediatric Oncology, Academic Medical Center, Emma Children’s Hospital, University of Amsterdam , Amsterdam, Netherlands
                [45] 45Dutch Childhood Oncology Group (DCOG) , Den Haag, Netherlands
                Author notes

                Edited by: André F. S. Amaral, Imperial College London, UK

                Reviewed by: Salman M. Tajuddin, National Institutes of Health, USA

                *Correspondence: Siegal Sadetzki, Cancer and Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Tel Hashomer 5262000, Israel e-mail: siegals@ 123456gertner.health.gov.il

                This article was submitted to Epidemiology, a section of the journal Frontiers in Public Health.

                Article
                10.3389/fpubh.2014.00124
                4172002
                25295243
                5795224b-18ed-4c6c-800f-965dcd8f5afd
                Copyright © 2014 Sadetzki, Langer, Bruchim, Kundi, Merletti, Vermeulen, Kromhout, Lee, Maslanyj, Sim, Taki, Wiart, Armstrong, Milne, Benke, Schattner, Hutter, Woehrer, Krewski, Mohipp, Momoli, Ritvo, Spinelli, Lacour, Delmas, Remen, Radon, Weinmann, Klostermann, Heinrich, Petridou, Bouka, Panagopoulou, Dikshit, Nagrani, Even-Nir, Chetrit, Maule, Migliore, Filippini, Miligi, Mattioli, Yamaguchi, Kojimahara, Ha, Choi, Mannetje, Eng, Woodward, Carretero, Alguacil, Aragones, Suare-Varela, Goedhart, Schouten-van Meeteren, Reedijk and Cardis.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 17 July 2014
                : 05 August 2014
                Page count
                Figures: 1, Tables: 4, Equations: 0, References: 27, Pages: 10, Words: 7929
                Categories
                Public Health
                Methods Article

                children,adolescents,brain tumors,elf–emf,mobile phones,rf-emf

                Comments

                Comment on this article